Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

CRH Medical Corporation T.CRH

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies

CRH Medical Corp provides physicians with products for the treatment of gastrointestinal diseases. The Company's product, CRH O'Regan System is a single use, disposable, hemorrhoid technology used in treating hemorrhoid grades I - IV.
Price: $2.41 | Change: +$0.02 | %Change: +0.84%
Volume: 248,875 | Day High/Low: 2.50/2.32 | 52 Week High/Low: 2.50/0.61
View modes: 
0 stars

new 52 week high

as investors make bets.... cheers, dave.  rate and reply
3 stars

RE:RE:RE:RE:RE:Has anyone thought about...

DGI is not a good example. In calculating net income there was amort of intangibles, restructuring provisions, large finance expenses, other one-off non-cash charges. That is why EBITDA gets used to...read more
0 stars

RE:RE:RE:RE:RE:Has anyone thought about...

GAA is a provider of anesthesia services and has strong financial performance with more than US$25 million in revenue and US$16 million in EBITDA for the 12 months ending June 2014. Read more at http:...read more
0 stars

RE:RE:RE:RE:Has anyone thought about...

A company I follow (DGI) had an EBITDA of $14 million for the first 9 months of 2014 but only wound up with a profit of about $3 million.  Until we see the financails for the new CRH  it seems...read more
1 star

new 52 week high

enjoy. cheers, dave.  rate and reply
0 stars

Proficting of the brief bear spell

to add to my positions View Event Date Event Opportunity Type Close at Event Target Price Range Jan 21, 2015 Slow...read more
0 stars

RE:Analyst Recommendation

Thanks for this!  rate and reply
0 stars

sp across 2 been a good bottomfish

amidst all the walls of worry 2014 wasn't as bad as it was and 2015 should also be not as dire as people think. cheers, dave.  rate and reply
0 stars

RE:Any interest ?

landlord: I doubt they would be interested in it. It seems to me CRH is going for immediately accretive and very juicy deals in their new space. If there are more of these deals out there, I hope they...read more
0 stars

Any interest ?

Just came across this small biotech company trading at a 52w low today, T.ATE : Antibe Therapeutics,  involved in the development GI safe medication, Jonathan Goodman from Knight is a director there...read more
0 stars

RE:RE:Analyst Recommendation

Sorry,  MSL is down from its fifty-two week high of $2.68, not two week high.  Cheers.  rate and reply
0 stars

RE:Analyst Recommendation

T-MSL  is trading at $1.70, down from it's two week high of $2.68. I think it was called a can't miss.  I don't remember the names of the analysts pumping MSL.  GLTA.  rate and reply
1 star

New 52 wk High

Next big blocks (52000) at $2.28 then again at $2.40.  rate and reply
5 stars

Analyst Recommendation

Second half of the clip. GLTA http://www.bnn.ca/Video/player.aspx?vid=530819 2015-01-14 COMMENT Bruce Campbell (2) CRH Medical (CRH-T) or Merus Labs (MSL-T)? These are not really comparable...read more
0 stars

huge volume

anyone have any idea why the high volume.  Lots of anon seling to anon.  rate and reply
0 stars

RE:RE:RE:RE:RE:NASDAQ listing...

Of course, the company could do a stock consolidation and become immediately Nasdaq eligible, much like NHC was planning to do but is no longer necessary because of the recent price increase. NHC's...read more
0 stars

RE:RE:RE:RE:NASDAQ listing...

Iscfa: Good point. Since the price is $2.00, they can only meet the Market Value Standard right now, hence the 90 consecutive day requirement. If the price were to reach $3.00, they could qualify...read more
5 stars

RE:RE:RE:NASDAQ listing...

Yes, possibly eligible if can trade above $2.00 U.S. for 90 days. * Currently traded companies qualifying solely under the Market Value Standard must meet the $50 million Market Value of Listed...read more
5 stars

RE:RE:RE:NASDAQ listing...

There is a footnote attached to the $2.00 price -  ** To qualify under the closing price alternative, a company must have: (i) average annual revenues of $6 million for three years, or (ii) net...read more
0 stars

RE:RE:NASDAQ listing...

Iscfa: I was looking at this: https://listingcenter.nasdaqomx.com/assets/initialguide.pdf If you scroll down to page 9 and look at the bottom number of the middle column, you can see the $2.00...read more